Taken together, these studies demonstrate that exceptionally broadly reactive neutralizing antibodies ... Moreover, their identification and characterization may lead to insights into HIV-1 ...

But promising results from a recent clinical trial suggest that broadly neutralizing antibody therapy (bNAbs) may be able to accomplish the next best thing. Data from the trial—a collaboration ...

Remarkably, the broadly neutralizing antibody VRC01 locks the complex ... an additional important aspect of the open trimer: the identification of central α-helical densities representing the ...